Apellis has had its highs and lows this year. Read what makes APLS a stock to watch for potential short-term gains before and after approval.

The roommate of Sebastian Zapeta, the Guatemalan migrant who police say horrifically killed a woman by setting her on fire as ...

The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...

Tiziana Life Sciences develops foralumab for treating neurodegenerative diseases like SPMS and Alzheimer's, with promising ...

New York’s previous three mayors won their second terms with ease and with minimal opposition from their own party. Eric ...

Jake Paul vs. Mike Tyson was a huge commercial success. Is Paul moving toward a fight with Conor McGregor? Here's everything ...

Lamar Jackson vows to catch the Christmas Day halftime show of Beyoncé during Baltimore Ravens' game against the Houston ...

Despite the Indiana Pacers establishing themselves as the team to beat last season, making a trip to the Eastern Conference ...

With less than a month until President-elect Donald Trump and his Vice President, Ohio Sen. JD Vance, are inaugurated, the ...

The mega-blockbuster weight loss GLP-1 drug is now also approved to treat obstructive sleep apnea in adults with obesity, in ...

A deal with Shanghai Jemincare Pharmaceutical has filled the hole. Rapt is paying $35 million upfront, plus up to $672.5 ...

Letters: We need sanctions with real teeth. Mike Carey helping take on falls. Privatizing the postal service terrible idea.